Zyprexa News
Study finds rapid weight gain among children taking Zyprexa, Risperdal, Seroquel
Children and adolescents who are prescribed a type of psychiatric drug known as atypical antipsychotics face an increased risk of rapid weight gain and other metabolic changes, according to a new study in the Journal of the American Medical Association. According to the authors of the study, these changes could increase the children’s risk of diabetes, hypertension or other related conditions. More »
FDA cites ‘safety concerns’ with new form of Zyprexa
An analysis by the Food and Drug Administration has found that a new injectable version of the schizophrenia drug Zyprexa has a “serious safety concern” because it has a high risk of causing extreme sleepiness. The FDA conducted the analysis ahead of an advisory panel meeting that will convene this week to review the new version of Zyprexa.
Parents file Zyprexa lawsuit over son’s death
The parents of recent college graduate have filed a Zyprexa lawsuit in Texas against the drug’s manufacturer, Eli Lilly & Co. Charles and Kaye Sexton’s lawsuit alleges that their son, Scott, died of pancreatitis as a result of taking the psychiatric drug Zyprexa. They also allege that Eli Lilly concealed information about the side effects of Zyprexa and misled consumers about the safety of the drug.
Study finds Zyprexa less effective, more hazardous than competitor
A new study of two leading schizophrenia drugs has found that the rate of side effects for patients taking Risperdal Consta was much lower than for patients taking Zyprexa. The study, published in the British Journal of Psychiatry, also found that Risperdal Consta was more effective at treating the long-term symptoms of schizophrenia than Zyprexa.
Judge’s ruling may allow additional Zyprexa lawsuits to proceed
Experts say that a letter sent to Eli Lilly & Co. in March by the Food and Drug Administration could mean even more lawsuits for the company over its antipsychotic drug Zyprexa. Lilly has paid more than $1.2 billion to settle roughly 29,000 claims that the drug could cause diabetes, weight gain and pancreatic infections.
Lilly settles 900 Zyprexa lawsuits
Eli Lilly & Co. has agreed to settle the claims of 900 former patients who have filed Zyprexa lawsuits against the company. The new agreement brings the total number of settlements reached in Zyprexa lawsuits to more than 26,000. No financial terms of the new settlements were disclosed.
Psych drugs may have contributed to Cho’s rampage at Va. Tech
Cho Seung-Hui, who murdered 32 students and faculty members at Virginia Tech before killing himself on April 16, is drawing the attention of gun-control advocates. But his medicine cabinet is also of some interest since psychiatric drugs have been linked with dozens of school shootings in the last two decades
Senator asks Lilly to turn over Zyprexa documents
A Republican senator has asked drugmaker Eli Lilly & Co. to turn over documents relating to the potentially illegal marketing of its antipsychotic drug Zyprexa. Sen. Charles Grassley says concerns that Lilly marketed the drug to doctors for off-label use, even while it was aware of the risk of Zyprexa side effects.
Investors file Zyprexa lawsuit over lost earnings
A pair of former investors has filed a Zyprexa lawsuit against Eli Lilly & Co., charging that the company cost shareholders more than $30 billion by marketing the drug for unapproved uses. Zyprexa lawsuits have also been filed against Lilly by former patients, who allege they developed diabetes after taking the drug and by seven state attorneys general, who have accused the company of marketing the antipsychotic drug for unapproved uses, including dementia, depression and autism.
Montana sues Eli Lilly for illegal Zyprexa marketing
The Montana attorney general’s office has filed a Zyprexa lawsuit against Eli Lilly & Co. over allegations the company illegally marketed the antipsychotic drug for unapproved uses. The lawsuit is seeking reimbursement for prescription costs paid by the state through programs like Medicare, as well as damages for any injury to patients.